Education
About Us
Working with TipRanks
Follow Us
Zydus Lifesciences Limited (IN:ZYDUSLIFE)
:ZYDUSLIFE
RESEARCH TOOLSreports
Arm1, Arm 2
Ulcerative Colitis
Phase II
Completed
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
Feb 08, 2024
―
Zyil1 Capsules 25 Mg And Zyil1 Capsules 50 Mg
Amyotrophic Lateral Sclerosis
Phase II
Completed
Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis
Jul 31, 2023
―
Zy19489 + Ferroquine (Fq)
Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria
Phase I
Recruiting
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
Jun 04, 2023
―
Saroglitazar
Type 2 Diabetes, Obesity, Metabolic Syndrome, Dyslipidemias, Nafld
Phase IV
Recruiting
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
May 13, 2023
―
Desidustat
Anemia Of Chronic Kidney Disease, Chronic Kidney Diseases
Phase IV
Recruiting
A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
Aug 23, 2022
―
Pertuzumab (Zrc-3277), Pertuzumab (Perjeta®)
Metastatic Breast Cancer
Phase III
Completed
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)
Feb 26, 2022
―
Zyil1 Capsule
Cryopyrin Associated Periodic Syndrome
Phase II
Completed
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
Dec 23, 2021
―
Zy19489 Capsule
Malaria
Phase I
Completed
A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects
Aug 04, 2021
―
Zyil1 Capsule
Healthy
Phase I
Completed
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers
Jul 15, 2021
―
Zyil1 Capsule
Healthy
Phase I
Completed
Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers
Jan 25, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Zydus Lifesciences Limited (ZYDUSLIFE) have in its pipeline
ZYDUSLIFE is currently developing the following drugs: Arm1, Arm 2, Zyil1 Capsules 25 Mg And Zyil1 Capsules 50 Mg, Zy19489 + Ferroquine (Fq). These drug candidates are in various stages of clinical development as the company works toward FDA approval.